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It is generally accepted that antigen recognition is a prerequisite for the induction 
of antibody formation, that recognition first occurs at the cell surface, and that the 
receptors involved have antibody-combining sites. By hypothesis, the specific combina- 
tion of antigen with its receptor(s) results in activation of immune differentiation and 
subsequent synthesis of antibody, although under certain conditions specific inactiva- 
tion and tolerance can ensue (1, 2). Antigen receptors located on the surface of certain 
lymphoid cells  (3-9) are considered to be representative of the eventual cell product 
with regard to both specificity and immunoglobulin class (10-13). Therefore, the use 
of antibody directed against a particular class of heavy chain determinants displayed 
by antigen receptors could conceivably lead to the selective inhibition of the produc- 
tion of that immunoglobulin class resulting in an experimental dysgammaglobulinemia. 
There are  now a  number  of experimental  findings  that  demonstrate  suppressive 
effects  on immunological responses as the result of exposure to anti-immunoglobulin 
sera  including,  (a)  anti-allotype-induced  suppression  (14-16),  (b)  anti-idiotype- 
induced  suppression  (17,  18),  (c)  suppression  of cell-mediated  hypersensitivity  and 
transplantation  reactions  in vitro  (19),  (d)  inhibition  of rosette formation  (20),  (e) 
in vivo suppression of immunoglobuljn synthesis in germfree animals (21),  (f)  sup- 
pression of the primary plaque-forming cell  (PFC) 1 response to foreign erythrocytes 
in vivo (22) and in vitro (23, 24), and (g) inhibition of the cellular transfer of immuno- 
globulin synthesis (25). The cellular basis for many of these immunosuppressive effects 
is still  very uncertain. 
We  now  report  findings  that  demonstrate  that  treatment  of conventional 
Swiss mice from birth  through young adulthood with  antimouse TA-globulins 
results  in  a  serum-~/A  deficiency  with  normal  production  of  3'M  and  ~/G 
and  with  an  essentially  normal  complement  of  3,A-containing  cells  in  the 
gastrointestinal  tract.  Treatment  with  anti-TM-globulin  preparations  re- 
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suited  in  a  profound  generalized  suppression  of  "yG  and  3'A  as  well  as  7M 
synthesis  similar  to  the  effects  reported  by  others  (21,  22).  In  addition,  a 
severe form of wasting disease resulted from anti-yM  but not anti-'yA and anti- 
3'G  treatment,  with  the  dose  and  the  time  of  administration  of  antiglobulin 
being critical factors in the development of this syndrome. 
Materials and Methods 
Animals.--Conventional Swiss mice, purchased from the Jackson Laboratory, Bar Harbor, 
Maine, were used in all experiments. This strain was chosen for these studies because of ease 
in mating and large litter size. Mouse litters were weaned on day 21. 
Hemolytic Plaque Assay.--The  localized  hemolysls-in-gel technique was  used  with  the 
modifications of Wortis and Dresser (26) to detect mid enumerate cellular synthesis of yM- 
antibody (direct PFC). Fresh frozen pig serum diluted at 1:9 with saline served as a source of 
complement. Class-specific rabbit antimouse 7A- and 3'G-immunoglobulin preparations were 
titrated to determine the optimal dilutions for development of indirect 3'A and 3~G PFC  as 
previously described  (27).  The number of indirect PFC  was calculated as the total plaques 
developed with facilitating antisera minus the plaques on identical plates with added comple- 
ment only (direct PFC). 
Hemagglutlnatlon Determlnatlon.--Sheep  red blood cell (SRBC) hemagglutinins (HA) were 
titrated  in  disposable  plastic  plates  using  a  Cooke  microtiter  (Cooke  Engineering  Co., 
Alexandria, Va.). The results were read after 2 h incubation at 37°C. Titers were expressed as 
log~ of the reciprocal of final dilutions showing HA observed macroscopically. The fraction of 
the total HA activity resistant to treatment with 0.1  M  2-mercaptoethanol (2-ME) was de- 
termined by incubation for 1 h  at room temperature. Antibodies resistant to 2-ME were re- 
garded as 7S, and those 2-ME sensitive as 19S. 
Serum Immunoglob~din Levels.--Serum immunoglobulin levels were  determined  by  the 
serial dilution Ouchterlony gel diffusion technique described by Arnason et al.  (28).  These 
values were reported as the reciprocal of the highest twofold dilution producing a distinct band 
against a  commercial  (Meloy Laboratories,  Inc.,  Springfield, Va.)  class-specific antiserum. 
Mean  serum  levels  4-  standard  error for each  experimental group  were  calculated  as  the 
numerical average of the individual values. 
Antisera.--Monospeciflc antisera to mouse immunoglobu]ins were prepared in rabbits and 
in goats reported in detail elsewhere/ In brief, antigen was immunoprecipitated  by  double 
diffusion in agar against specific antiserum and the preclpitin bands were cut out and injected 
with  complete  Freund's  adjuvant.  Three  different  antimouse #-chain  antisera  and  three 
different antimouse a-chain antisera were prepared. These included: rabbit antinormal mouse 
"I'M, rabbit anti-MOPC-104E tumor 3'M, goat antinormal mouse 3,M, rabbit antimouse milk 
3'A, rabbit anti-MPC-1 myeloma "yA, and goat anti-MPC-1 myeloma 3~A. When necessary, 
absorption of  minor contaminants was  done with newborn mouse serum.  Polyva]ent anti- 
mouse "g-chain  antiserum was made in goats by injecting a  mixture of papain Fc fragments 
from  MOPC-31C,  Adj-PC5,  and  MOPC-195  myeloma  proteins,  which correspond  to  the 
3'G1, 7G2a, and 3'G2b subclasses of ~G. Antimouse 3'G3 was made in rabbits with the J-606 
(kindly supplied by Dr. Howard Grey) and absorbed with a mixture of purified MOPC-31C, 
Adj-PC5, and MOPC-195 myeloma proteins. Multiple controls for the monospecificity of each 
antisera were done, including immunofluorescent staining of myeloma tumors representative 
of the major immunoglobulin classes. All sera injected into newborn mice were submitted to 
the following treatment. The %globulin fraction was obtained by sequential precipitation with 
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18%,  12%, and a second 12% Na~SO4. After exhaustive  dialysis of the precipitate against 
saline and clarification by ultracentrifugation, the protein concentration was adjusted to 100 
mg/ml and the antisera sterilized by Millipore filtration (Millipore Corp., Bedford,  Mass.). 
For the Jerne hemolytic plaque assay., facilitating antisera monospecific for mouse a-chains 
were made in rabbits using the MPC-1 myeloma protein. The previously described polyvalent 
goat antimouse "y-chain antiserum ~aas used to facilitate TG PFC. The optimal dilution of the 
anti-3'A-antiserum was 1 to 20 and of the anti-3,G-antlserum  was 1 to 100. 
Hislologlcal Sludles.--The immunofluorescent technique  of Coons (29), with the modifica- 
tions previously described,  a was used to enumerate plasma cells belonging to different immuno- 
globulin classes. 
The plasma cell population of the intestine was evaluated in sections from the initial por- 
tion of the small bowel by counting the number of "yA-cel]s  in 100 consecutive longitudinally 
cut villi. Since very few 3'M- and TG-plasma cells are found in the normal mouse intestine, 
quantitation of these plasma cell classes was not attempted. 
In the case of the spleen, one part of the organ representing  ~/~ to 1/~0 of the total spleen 
weight was sectioned  and used for histological studies.  The remaining  portion of the spleen 
was used for the Jerne plaque assay. The figures reported in the results section refer to counts 
of 7M-, TA-, and "},G-plasma  cells in two sections, cut 12/zm apart in the tissue block to include 
different cellular groups. 
RESULTS 
Suppression  of Antibody  Synthesis  in  Mice  Treated with  Anliglobulins.-- 
Experiments  were  first  attempted  in  which  animals  were  injected  with  ap- 
proximately 10 mg of globulin in 0.1 ml at 24-h intervals beginning within 12 h 
of birth.  However,  this regimen resulted in a  high incidence of deaths in  the 
first few days of life. These deaths occurred randomly among controls, anti-/*-, 
and anti-s-treated mice and were attributed to the trauma of constant handling 
and injections. No early deaths occurred when animals were similarly injected 
at  48-h  intervals;  therefore,  this  schedule  was  maintained  throughout  these 
experinlents. 
The  duration of antiglobulin treatment necessary for effective immunosup- 
pression in vivo was not known.  Therefore,  experiments were  done  in  which 
antiglobulin treatment was continued from birth through young adulthood to 
within 48 h  of sacrifice for antibody assays. Antibody responsiveness to SRBC 
was  assessed  by  measuring  PFC  and  humoral  hemagglutinating  antibody 
(serum  HA)  titers  4  and  10  days  after  primary  intraperitoneal  injection  of 
5  )<  l0  s SRBC. The effects of continuous antiglobulin treatment on the anti- 
body response to SRBC are shown in Table I, exps. 1 (day 4 assays) and 2 (day 
10  assays).  In  exp.  1,  anti-'l,A  treatment  somewhat  depressed  direct  PFC 
numbers,  but showed no effect on  2-ME-sensitive serum  antibody levels sug- 
gesting little effect on TM-antibody. Anti-'gM-treated mice had no detectable 
humoral or cellular antibody response. Day 10 assays (exp. 2) show that mice 
treated with anti-q,A have partially depressed 3'G PFC responses and essentially 
complete suppression of "),A PFC. Again, as in the first experiment, there is no 
a Mattioli, C. A., and T. B. Tomasl,  Jr.  1973. The life span of IgA cells from the  mouse 
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significant  effect on 2-ME-sensitive  serum antibody,  although 2-ME-resistant 
antibody  is  lowered.  Anti-3'M-treated  mice  are  completely  suppressed  in  all 
immunoglobulin classes. 
In a second series of experiments,  antiglobulin treatment was discontinued 6 
days before injection of antigen. Day 4  antibody assays (Table I, exp. 3)  show 
that anti-yA treatment has no suppressive effect on either direct PFC or serum 
HA  levels,  while  the  antibody  responses  of  anti-3,M-treated  mice  were  sig- 
nificantly suppressed.  Antiglobulin  treatment in these animals was terminated 
10 days before time  of assay. Day  10  antibody  assays  (exp.  4)  that were per- 
formed 16 days after the last injection of antiglobulins demonstrated that even 
TABLE  I 
Effect of Antlglobulin  Treatment on  the  Primary PlaTte-Forming  Cell and Serum Antibody 
Responses to SRBC 
Exp. 
no 
i Time I  Mean no. PFC/106  spleen  },lean reciprocals of anti- 
i 
Time"  cello 4- SE  SRBC HA titers 4- SE 
Treatment  [SRBC/  J 
Controls  6 
Anti-yA  3 
Anti "yM  12 
Controls  4 
Anti-yA  6 
Anti-yM  5 
Controls  13 
Anti-yA  8 
Anti-yM  7 
Controls  2 
Anti-yA  5 
Anti "yM  6 
No.  .~- 
of  o¢  Total 
ani-  I-  ~  I dose  maIs ' treat 
gent  .__ 
i 
ays  mg 
-21  100 
21  100 
-21  i00 
0-27  120 
0-27  120 
0-27  120 
0-26  80 
0-26  80 
0-26  80 
0-26  80 
0-26  80 
0-26  80 
20 
20 
20 
32 
32 
32 
32 
32 
32 
assay ] 
day 
24 
24 
24 
30 
30 
30 
36 
36 
36 
42 
42 
42 
3c~1  7A 
78  4-  23 
5  4- 5 
0.3  4-  0,3 
G  I  2-ME 
_2  .__  .... itive__ 
3.3  4- 0.3 
101  4- 4  [ 4.0 0~ 0.2 
60  4-  9  3,3  0.7 
0.7  =E  0.7 
f 
,5.8  4- 0.3 
5.3  4- 0.5 
1.64-0.3 
574  4-  87  /  3.6  4- 0.2 
320  4-  49  I 5.6  4- 0.5 
94-9  ] 0.74-0.7 
i 
130  4-  17 
64  ~t=  8 
77  =t=9 
50  4-  10 
0,6  4-  0.4 
336  4- 30 
402  :~=  142 
133  ::1= 36 
104  4- 6 
110  =k: 8 
22  =h  21 
521  4-  162 
161  4- 46 
9  4- 9 
2-ME 
resistant 
2.8  4-  0.3 
1,3  4- 0.3 
0 
3.0  4-  0.3 
3.0  4- 0.4 
0.5  4- 0.5 
with  treatment  of  shorter duration,  anti-~M-globulin  retained  its  potent im- 
nmnosuppressive  activity.  Anti-TA  also  suppressed,  but  only  the  yA  PFC 
response, with little effect on the other antibody classes. The greater numbers 
of PFC in control animals from exps. 3 and 4 compared with those from exps.  1 
and 2 can be attributed to age differences at the time of antigenic stimulation. 
It was considered of practical as well as theoretical importance to determine 
the necessary duration of treatment and the concentration of anti-'yM required 
for immunosuppression.  The  results presented in Table  II  show that  mice in 
which anti-3'M  treatment was terminated 2  days  after birth were suppressed 
to almost the same extent as mice that received continuous long-term treatment 
through young  adulthood.  Mice  that  received  various concentrations of anti- 
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responses even at the lower dilutions (Table III). It is interesting that from the 
data obtained at the lowest dilution that 3'M recovery may precede that of 3'G 
and 3'A. Also to be noted is that 20 mg of anti-3,M elicited similar degrees of 
immunosuppression  when  injected  on  a  short-term  regimen  in  concentrated 
form (Table II) or on a long-term regimen in diluted form (Table III). 
Suppression  of Serum  Immunoglobulin  Levels  in  Mice  Treated  with  Anti- 
globulins.--Serum  immunoglobulin levels  in antiglobulin-treated mice are pre- 
TABLE II 
Effect of Duration of Treatment with Anti-'yM on the Primary Plaque- 
Forming Cell Response 
Exp.  Treatment  no. 
1  Controls 
Anti-TM 
Anti-TM 
2  Controls 
Anti-'gM 
Anti-'gM 
No. oi  Dura-  tion of 
__animals  treat-ment 
I 
~l  Total 
[  dose 
days 
0-21 
0-21 
0-2 
0-27 
0-27 
0-2 
Time 
SRBC 
given 
day 
20 
2O 
20 
2O 
20 
20 
Time 
of PFC 
assay 
day 
24 
24 
24 
30 
30 
30 
Mean no. PFC/2 spleen ceils 4- SE 
5~M  7A  5~G 
128  4- 23 
0 
13  4-  10 
774-9 
0.6  4- 0.4 
11  4- 2,4 
78  4- 23  10l  4- 4 
0.3  4- 0.3  0.7  :t= 0.7 
13  =l:: 5.2  30  4-  10.6 
Efl?ct of Dose of Anti-" 
Treatment 
Controls 
Anti-3,M 
Anti-'gM 
Anti-3'M 
INto. O[ 
animals 
3 
6 
2 
3 
[ nuratio 
__trea~fer 
day 
0-26 
0-26 
0-26 
[  0  26 
TABLE III 
,M on the Primary Plaque-Forming Cell Response 
?otal 
:lose 
mg 
80 
8O 
4O 
2O 
Tim~  Time 
SRBI  of PFC 
giver  assay 
day  day 
32  42 
32  42 
32  42 
32  42 
Mean no. PFC/10 6 spleen cells :k SE 
'yM  "YA  'yG 
104 4-  11 
22  4-  21 
194-9 
55  4-  24 
209  4-  56 
94-9 
24-1 
11  4-  11 
249  ±  33 
94-9 
0 
11  =t=  11 
sented in Table IV. The results  clearly demonstrate  a  selective deficiency of 
serum  3,A-immunoglobulins in  anti-3,A-treated  mice.  Serum-3,G3  concentra- 
tions  were  found  to  be  normal  in  anti-3,A-treated  animals.  A  selective  sup- 
pression of 3'A occurred concomitantly in the serum (mean 7A level  =  1) and 
intestinal washings (mean 3'A level  =  1.25) of four 40-day old animals treated 
from birth with 180 mg of anti-'yA. Four control animals similarly treated with 
normal goat globulins had a mean serum-~A level  of 7 and intestinal fluid-~A 
level of 4 (see footnote of Table IV for method of measurement). Rabbit anti- 
bodies to mouse-3,A  were detectable by double diffusion analysis in the sera of 
only 2 of the 16 animals treated with anti-3,A-globulin. Immunoglobulin levels 214  ANTI-IG-INDUCED  RUNTING  AND  ~A  DEFICIENCY 
of all classes including 3,G3 were suppressed in animals treated with anti-3,M- 
globulin. Circulating antibody to mouse-3'M was below  the level of detection 
by double diffusion analysis in all #-treated mice.  As shown by exp. 4, Table 
IV,  antiglobulin-induced suppression of serum immunoglobulin levels was ob- 
served for more than 2 wk after termination of treatment, which again suggests 
this type of inhibition has long-lasting effects. 
Immuno/tuorescent  Analysis of Lymphoid  Tissues.--Tissue  sections of spleen 
and intestine from 30-day old mice given long-term treatment with anti-'yM-, 
anti-~,A-, or normal ~/-globulins were examined for plasma cells containing ~/M, 
3'A, and 3'G by the indirect immunofluorescent technique. Due to the relatively 
TABLE IV 
Effect of Antiglobulin Treatment on Serum Immunoglobulin Levels 
Exp. 
no.  Freatmen 
Controls 
Anti-q,A 
Anti--/M 
Controls 
Anti-TA 
Anti-5'M 
Controls 
Anti-'/A 
Anti-3'M 
Controls 
Anti-TA 
Anti-3"M 
Ng"  Duration 
t  oI  ]  of  treat-  anl- 
6  0  21 
3  0  21 
6  0-21 
7  0-27 
6  0-27 
12  0  27 
13  0-26 
4  0-26 
4  0-26 
4  0-26 
3  0  26 
3  0-26 
Total 
dose 
mg 
100 
100 
100 
120 
120 
120 
~0 
80 
80 
80 
80 
80 
Time 
SRBC 
given 
day 
20 
20 
2O 
20 
20 
20 
32 
32 
32 
32 
32 
32 
Time of 
serum 
collection 
day 
24 
24 
24 
36" 
36 
36 
42 
42 
42 
Mean serum immunoglobulin 
levels*  4- SE 
7M 
84-0 
7::t=1 
0 
74-I 
84-0 
14-1 
104-1 
16±0 
64-2 
124-4 
134-3 
7--5 
yGi 
8b  4-  21 
75  4- 28 
17  4-5 
59  4-5 
53  4-7 
19  4-6 
284-6 
60  4- 25 
164-6 
48  4-  16 
37  4-  14 
194-7 
"~G2 
54-1 
74-1 
24-1 
32  4-9 
17  -I-3 
94-5 
13  4-3 
214-5 
64-1 
124-4 
t14-3 
74-1 
* Expressed  as  the highest  reciprocal  serum  dilution  showing  distinct  precipitin  bands  in  Ouchterlony  gel 
diffusion  using commercial  (Meloy)  class-specific  antiscra. 
small numbers of plasma ceils normally present in the spleen of animals of this 
age two sections were scanned. These sections were cut 12/~m apart in the tissue 
block  to  include  different  cell  clusters  and  to  compensate  for  the  irregular 
distribution of plasma cells. As depicted in Fig. 1 (3M, 3A, 3G) and quantitated 
in Table V, the spleens of anti-~'M-treated animals are completely devoid of all 
immunoglobulin-containing  cells.  Compared  with  controls,  anti-3'A-treated 
animals showed no differences in the numbers of "yM- and 3,G-containing plasma 
cells in their spleens, while 3,A-plasma cells were substantially diminished (Fig. 
1 [2M, 2,4, 2G] and Table V). Thus, the effect of anti-TA treatment on splenic 
plasma cell development was concordant with its effect on antibody and immu- 
noglobulin synthesis. 
Immunofluorescent analysis of the intestines of antiq~-treated mice revealed R.  A.  MURGITA~  C.  A.  MATTIOLI,  T.  B.  TOMASI,  JR.  215 
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Fro. 1. Immunofluorescence of spleen sections from control, anti-3,A-, and anti-'gM-treated mice. Tissue sections 
'ere stained with rabbit antimouse "yM(M), "yA(A), and 3'G(G).  1M,  1A, and 1G show spleen sections from mice 
reared with normal "}'-globulin.  2241, 2-,t, and 2G are spleen sections from  anti-3,A-treated mice and  demonstrate 
L selective absence of 3'A- containing cells.  Sections 3M,  3A,  and 3G are from  anti-3~M-treated mice  and  exhi- 
sit  the virtual  complete elimination of immunoglobulin-eontaining cells. X  184. 216  ANTI-IG-INDUCED RUNTING AND  '~A  DEFICIENCY 
a complete absence of the 3,A-plasma cells that are normally present in control 
animals (Fig. 2 A and B and Table V). Surprisingly, the numbers of 3,A-plasma 
cells in  the  lamina propria of  anti-TA-treated  animals  did  not  differ signifi- 
cantly  from  controls  (Fig.  2 C  and  Table  V).  Linear  deposits  of  rabbit  3'- 
globulin in  the  lamina  propria and  along  the  basement  membrane  were  ob- 
served in these animals (Fig. 2 D), indicating that the anti-'yA  gained access to 
the lamina propria. However, a quantitation of the relative concentration of the 
TABLE  V 
Effect of Antiglobulin  Treatment on Plasma Cell Development in 
Lymphoid  Tissues 
Spleen  Intestine 
Treat- 
ment*  ~/M-plasma cells  3,A-plasma  cells 
Anti-~/A 
Anti-3,A 
Anti-'gA 
Anti..'~A 
Anti-vA 
Anti-)A 
Anti-3,M 
Anti-3.M 
Anti 3~M 
Control  83 
Control  54 
Control  103 
Control  88 
93 
118 
13 
89 
123 
62 
++  2~SE~ 
110  102  ~  9 
129 
128 
t23 
/ 
48 /  78  ==  13 
12 
18 
113 
151 
91 
0[  0 
1 
16 
11 
4 
76 
2  Y~±SE 
2  0  4!1 
0  6 
0  0 
8  8 
9  12 
4  4 
0  0  0 
0  0 
0  0 
~G-plasma ceils  No. of 7A- 
plasma 
-  ~--  cells/100  2 ~: SE 
1  2  2 ±  sE  villi 
...... 
15  20  I 61  =k 30  J  1,329  1,  7 
21  23  /  I  1,081 
34  x3]  ]  1,053 
104  257  1,254 
179  107  ,  77  4-  13  [  123  836  ::k  175 
30  32  1,060 
30  39  955 
72  69  896 
103  76  1,374 
102  87  605 
0  o  0  ND  0 
0  0  0 
0  0  o 
* Animals were treated from birth through day 27 with 120 mg of gamma  globulins  and were 30 days old at the 
time of sacrifice. 
} Plasma cell counts  from two different  spleen  sections  cut 12/~in apart. 
§ Mean plasma cell numbers ::h standard error. 
anti-3,A-globulins in the circulation vs. lamina propria interstitial fluid was not 
possible. 
Histology of Anli-vA-  and Anti-3,M-Treated Mice.--Thymus,  spleen,  and 
intestine from anti-'yA-treated mice showed a normal microscopic architecture 
and did not differ from control  animals when stained  with heniatoxylin-eosin 
FIG.  2.  Immunofluorescence of  sections  of  intestine  stained  for TA-containing cells.  (A), 
intestine from control mouse showing significant numbers of lamina propria "),A-plasma cells; 
(B), intestine from anti-~/M-treated mouse with lamina propria completely devoid of fluores- 
cent cells;  (C), intestine from anti-TA-treated mouse showing abundance of TA-plasma cells 
in  numbers approximately equivalent to  control;  (D),  intestine  from anti-TA-treated mouse 
stained  with  fluorescein-conjugated goat  antirabbit  T-globulin  demonstrating  deposition  of 
rabbit T-globulin within the lamina propria.  X  211. FIG. 2 218  ANTI-IG-INDUCED  RUNTING  AND  "~A  DEFICIENCY 
and  methyl  green-pyronin.  Specifically, there  was  no  indication  of  mucosal 
inflammation of the gastrointestinal tract, nor villus changes compatible with 
malabsorption syndrome. 
In the anti-/z-treated mice, the gross appearance of the thymus and intestine 
was normal,  while the  spleen was  reduced in  size, markedly so in  the runted 
animals. This was clearly reflected in the low cell counts of spleen cell suspen- 
sions  from  b~-treated  animals  (Table  VI).  Histologically, the  thymus  had  a 
normal  cortex and  medulla.  Hassall's corpuscles, lymphocytes, and  epithelial 
cells were unremarkable. The spleen had primary follicles, but a marked reduc- 
TABLE VI 
Spleen Ceil Counts o!" A nliglobulin-Trealed Mice 
Exp. no.  Treatment  No,  of animals  Age  Mean cell count  (X  10  ~) ~  SE 
days 
Controls  3  30  212  =E  26 
Anti-TA  3  30  245  ~  21 
Anti-TM*  3  30  104  =i: 39 
Controls  3  24  168  i  31 
Anti-5,A  --  24  -- 
Anti-TM*  6  24  83  ~  5 
Controls  4  42  137  =t=  13 
Ami 7A  6  42  158  =t=  12 
Anti 3&l*  3  42  91  :b  36 
Controls  3  36  165  ±  18 
Anti "yA  --  36  -- 
Anti 7M*  8  36  94  =i=  10 
* These data do not include severely runted animals who rarely' survived  longer than  15 
da3 s. 
tion of the lymphocyte population of the red pulp was observed. No germinal 
centers were seen in antiglobulin-suppressed animals. However, they were also 
not well developed in many of the control animals of comparable age making a 
quantitative  comparison  impossible.  Cells  from  the  myeloid,  erythroid,  and 
megacaryocytic series normally present in mouse spleen were unremarkable in 
antiglobulin-suppressed animals. The intestine showed  a  normal mucosa, with 
slender villi, but devoid of the normally abundant plasma cell population. The 
complete  absence  of  plasma  cells  from  the  spleen  and  gut  of  mice  heavily 
treated  with  anti-#  were  nmst  clearly demonstrated  by  immunofluorescence 
(Figs. 1 and 2). 
Evidence for Runting Syndrome in A nti-3,M-Treated Mice.--  A  high frequency 
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experiments designed  to determine the  amount and frequency of antiglobulin 
injections  that  newborn mice could sustain  and  remain healthy.  Runting  oc- 
curred in  all  of 30  animals from six litters injected  at 24-h  intervals starting 
within  12  h  of  birth  with  20 mg  of  anti-TM-globulins  in  0.2 ml.  30  control 
littermates injected with saline grew and developed normally.  Severe runting 
was first observed by 4 days at which time the injections were stopped. In this 
experiment the  treated  mice that  received approximately 80 mg of anti-'yM- 
globulins in four injections during  the first 4  days of life all remained runted 
until their death, which occurred in all runted animals within 15 days. Normal 
growth  and  development was observed in  all  animals  treated  with two  anti- 
Fro. 3.  10-day old antiglobulin-treated littermates. The severely runted animal received 
40 nag of rabbit antimouse 7M-globulin in four 10-mg intraperitoneal injections during the 
first 4 days of life. The control littermate was similarly treated with an equivalent amount of 
normal rabbit "y-globulin.  At day 10 the control animal weighed 5.2 g and the runted animal 
weighed 2.7 g. 
3,A-globulin  preparations,  two  anti-TG  preparations  (unpublished  observa- 
tions), and several pools of control normal rabbit or goat 7-globulins. Runting 
was  consistently  observed in  mice  treated  with  three  qualitatively  different 
anti-3,M-globulin  preparations  at  the  same  total protein  concentrations.  The 
establishment of this condition is dependent upon the dose of anti-TM-globulin 
injected since a series of 20-mg injections induced  100% lethal runting,  10-mg 
injections induced 20% runting, while 5- or 2.5-mg injections of anti-'I'M pro- 
duced immunosuppression but no severe runts.  While severely runted  animals 
rarely lived beyond  15  days,  those  anti-3,M-treated  littermates  that  escaped 
this  condition  survived  as  long  as  controls  or  anti-TA-treated  animals.  Il- 
lustrated in Table VII, however, are the lower weights of the surviving anti-3,M- 
treated  animals  compared with  controls  and  anti-TA-treated  animals,  which 
suggests  a  gradation  of  wasting  extending  from  short-lived  severe  runts,  to 
partial runts that survive, to animals approaching normal weight and develop- 220  ANTI-IG-INDUCED  I~UNTING  AND  ~A  DEFICIENCY 
ment.  Runting  could  be  initiated  by  a  single  10 mg injection  only if  it  was 
administered within 12 h of birth. Further attempts to induce runts with various 
doses and numbers of injections in mice older than 1 day were unsuccessful. In 
addition, after the 1st day, continued injections did not increase the number of 
runts but did advance the time of death of those already runted. 
DISCUSSION 
This study demonstrates that treatment of conventional newborn mice with 
anti-3,M-globulin causes extensive immunosuppression that affects the response 
TABLE VII 
Body Weights of Anti¢lob~din-Treated Mice 
Litter no.  Treatment 
Mean weights (g)  ~= SE  (no.  oi mice) 
Day 20  Day 35 
1  Controls  7.4  4-  0.2  (5)  20.0  ±  0.9  (5) 
Anti-TA  7.1  4-  0.3  (6)  19.6  4.  0.8  (6) 
2  Controls  9.6  4.  0,1  (3)  23.6  4-  1.9  (3) 
Anti-3,A  8.9  4-  0.2  (6)  24.0  4.  1.0  (6) 
3  Controls  8.5  4-  0.6  (5)  20.0  4.  4.5  (5) 
Anti-~A  8.2  4- 0.2  (6)  24.0  4- 0.7  (6) 
4  Controls  12.4  4.  0.3  (2)  23.5  4-  1.5  (2) 
Anti-3~M*  8.5  4-  1.3  (5)  19.9  -4- 2.5  (4) 
5  Controls  11.4  4-  0.6  (3)  25.0  4-  1.8  (3) 
Anti-3,M*  10.0  4-  0.2  (3)  23.5  4-  1,5  (3) 
6  Controls  10.6  +  0.3  (3)  26.5  4-  0.8  (3) 
Anti-3,M*  7.8  4.  1.1  (6)  16.8  -4- 3.5  (3) 
* These data do not include severely runted  animals who rarely  survived longer than 15 
days. 
in all immunoglobulin classes. Similar observations have recently been made by 
others both in vitro (24) and in vivo using germfree (21) as well as conventional 
(22)  animals.  Several  alternative  explanations  for the  immunosuppressive  ac- 
tivity of anti-3'M  on 3'G and 3'A in addition  to 3'M synthesis have been put 
forth involving either  the  sequential  and/or  simultaneous  expression  of 3'M-, 
~G-,  and 7A-antigen receptors on virgin precursor lymphocytes (21,  22,  24). 
Some evidence has accumulated that suggests that antiglobulins  directly sup- 
press  B  lymphocytes based  on:  (a)  in  vitro  reconstitution  experiments  with 
partially purified macrophages, B, and T  cell preparations showing suppression 
of the immune response when B  cells were exposed to anti-TM before culture, R.  A.  MURGITA,  C.  A.  MATTIOLI,  T.  ]3.  TOMASI,  ~R.  221 
but not when only macrophages and/or T  ceils were similarly exposed  (24); 
(b) studies showing suppression by anti-TM of antibody responses to thymus- 
independent antigens  (21, 22)  as well as suppression  in genetically athymic 
mice  (22);  and  (c)  demonstration  of normal  morphological development in 
thymuses  and  "thymus-dependent" areas  of  lymphoid tissues  in  anti-q/M- 
suppressed animals (21).  It is apparent from homograft studies (30)  that the 
T  lymphocyte population  that  mediates  transplantation  immunity is  not 
affected by anti-q/M. In addition, the collaborating T  lymphocyte is not sup- 
pressed by exposure to anti-q/M before in vitro (24) or in vivo (22) reconstitu- 
tion. 
Although the exact cellular basis for immunosuppression by anti-q/M remains 
speculative, presumably the interaction of anti-q/M with cell  surface antigen 
receptors of the #-chain type is a prerequisite. We presently favor the concept 
that  the  generalized suppression induced by anti-q/M depends on the initial 
presence of a  population of multipotential B  lymphocytes with surface q/M- 
receptors from which all the various classes of plasma cell clones arise through a 
maturation process probably occurring initially within the microenvironment 
of the mammalian bursa equivalent (BE). The severe runting that accompanies 
the early administration of high concentrations of anti-q/M shown in this study 
could, therefore, be a manifestation of a severely crippled immune system that 
is completely devoid of mature B  lymphocytes although just how this would 
affect growth and development is at present unclear.  That runting was not 
observed in previous studies (21, 22), probably results from the smaller effective 
doses of anti-q/M employed. 
Although this concept, as well as much of the previous work cited by others, 
emphasizes the B  lymphocytes as the site of action for antiglobulin, the pos- 
sibility that a subpopulation of T lymphocytes is involved should be considered. 
Thus, runting as well as the generalized immunosuppression induced by anti- 
q/M could be related to the inactivation of a T lymphocyte population expressing 
q/M-antigen receptors. Some evidence for surface q/M on T  cells has been pre- 
viously reported (20). The observations that cell-mediated immunity is intact 
in these animals and that the collaborating "helper" T lymphocytes necessary 
for the induction of certain antibody responses are unaffected by anti-q/M does 
not negate this premise since there is evidence that there may be several func- 
tional classes  of T  lymphocytes (31). Anti-q/M could block the function of an 
ontogenetic regulator T lymphocyte population that is distinct from the helper 
cell and is necessary to induce further differentiation of multipotential precursor 
B lymphocytes toward ",/M-, "yG-, and q/A-plasma  cells. 
The thymus appears to be of normal size in runted animals in contrast to the 
profound atrophy of this lymphoid organ commonly observed in other forms of 
wasting disease.  However, this does not preclude an anti-q/M-induced thymic 
defect of a more subtle nature. Because of the immediate arrest in development 
that is noted within 4 days in anti-q/M-runted animals, it is not unreasonable to 222  ANTI-IG-INDUCED  RUNTING  AND  "yA DEFICIENCY 
suspect that endocrine alterations are affecting ontogenetic maturation. In this 
regard, a  type of runting syndrome, perhaps involving the thymus, has  been 
reported  (32,  33)  after adrenalcorticosteroid administration.  Furthermore,  it 
has been demonstrated that  adrenalectomy ameliorates one form of wasting 
disease (34). In spite of certain common features that exist between the wasting 
diseases induced by cortisone and anti-TM, the normal gross and histological 
findings in the thymus of anti-3,M-induced runts are not consistent with the 
profound atrophy of this lymphoid organ observed after the administration of 
cortisone. Therefore, at present the precipitating etiological factors involved in 
antiglobulin-induced  runting  remain  highly  speculative and  experiments  are 
currently in progress to explore further the pathogenesis of this syndrome and 
its relationship with drug-induced wasting (33) as well as other forms of wasting 
disease (35-38). 
The possibility should be considered that antiglobulin-induced suppression is 
analogous  to chronic allotype suppression in mice  (15)  that may have as its 
cellular basis an active suppressing process that is transferable by spleen cells 
but not serum from suppressed animals. Jacobson et al.  (16) suggest that there 
is a population of cells in the spleen that arises as a consequence of exposure to 
antiglobulin,  which  is  capable  of  recognizing potential  immunoglobulin-pro- 
ducing cells  and preventing their expression. Their preliminary evidence that 
the anti-allotype-induced suppressor is a  thymus-derived cell suggests that T 
lymphocytes may play an important regulatory role on B lymphocytes and their 
immunoglobulin products. The finding that prolonged incubation of anti-3,M 
with spleen cells is necessary to obtain antiglobulin-induced suppression of anti- 
body synthesis in vitro (24) also suggests a suppression mechanism more com- 
plex than saturation of receptors and prevention of antigenic stimulation. 
Clones of cells with the capacity to synthesize ",/G are thought to arise by 
conversion from B  lymphocytes expressing 3'M-receptors. For a  few genera- 
tions,  cells  that  have  newly developed 7G-receptors may  also  express 7M- 
receptors (TM-TG-"double producers"). As postulated by Lawton et al.  (21), 
7A-producing ceils may arise from 3,G-cells by a similar sequence of ontogenetic 
events. Treatment with anti-3'G should, therefore, suppress 3'G, and if most or 
all 3,A-cells arise from 3,G-precursors, a significant suppressive effect by anti- 
7G on 7A should be observed. Our preliminary experiments designed to investi- 
gate this have been unsuccessful and thus far, our results with anti-3,G treat- 
ment have been equivocal except that these antiglobulins are not able to induce 
runting. Suppression by anti-3,G has been reported in vivo (22) and in vitro (24) 
but the effects are partial. The reason for partial and not complete suppression 
by  anti-3,G  in  vitro  is  not  apparent.  However,  in  vivo,  perhaps  the  large 
amounts of maternal 3'G present in the circulation of newborn animals eliminates 
much of the anti-3,G before it reaches the immune mechanism. The presence of 
circulating maternal T-globulins may also account for the inability of anti-3,M 
treatment to completely  eliminate serum-TG 1 and 3'G2 as observedin this study. R.  A.  MURGITA,  C.  A.  MATTIOLI,  T.  B.  TOMASI,  JR.  223 
A similar persistence of these two serum immunoglobulins in anti-q/M-treated 
animals was noted by others  (21,  22)  and  was  attributed  to  the presence of 
maternally  derived q/G1-  and  q/G2-antibodies  (22).  Our  data  showing  that 
splenic q/G PFC are suppressed (Table I) in anti-q/M-treated animals that have 
significant levels of serum-q/G (Table IV) would seem to be in agreement with 
this reasoning. However, it is also possible  that some of the nonsuppressible 
residual serum-TG derives from q/G-producing cell lines that were already fully 
differentiated and peripheralized before the start of antiglobulin treatment. 
Assuming that the q/A-plasma cell precursor is a lineage arising from q/G-cells, 
treatment with  anti-q/A  should  suppress  only q/A  with possibily some  slight 
effect on q/G via q/G-q/A-clones,  and should exert no effect on q/M. Our data, as 
well as in vitro (24) experiments, are consistent with this prediction. However, 
our findings do not exclude the possibility that some q/A-cells may arise directly 
from q/M-cells  without  an  intermediate q/G  stage.  In  fact,  if q/M-precursors 
differentiate into q/A-cells within the gastrointestinal tract, as suggested by this 
study (see below), the paucity of q/G-cells in the lamina propria is most easily 
explained by a direct q/M-q/A conversion. 
While animals treated with anti-q/A  had selectively suppressed serum-q/A,  as 
well as splenic q/A-plasma cells, the q/A-plasma cells in the lamina propria of the 
gastrointestinal  tract were  present  in  numbers  approximately equivalent  to 
those in the controls. The reason for this rather striking dissociation is not clear. 
Complete inaccessibility of the  antiglobulin  to intestinal  plasma  cells is not 
involved since linear deposits  of heterologous globulin  derived from the  ad- 
ministered  antisera  were  seen  within  the  lamina  propria  of most  anti-q/A- 
treated animals. Also, the possibility of qualitative differences between the q/A- 
receptors on intestinal q/A-plasma cells vs. splenic q/A-plasma cells seems un- 
likely since antisera directed against both secretory and nonsecretory types of 
q/A were used in these experiments with similar results. Moreover, no differences 
between the o~-chains of serum and secretory q/A have been observed in studies 
to date (39). A speculative suggestion that is consistent with the observed dis- 
sociation between systemic and secretory q/A-cells after anti-q/A  treatment and 
the complete suppression of all q/A-cells by anti-q/M is as follows: As mentioned 
previously, q/A-cells may arise from precursor lymphocytes having surface q/M 
possibly via an intermediate q/G stage. These early maturation events probably 
occur in the mammalian BE, perhaps the bone marrow itself. In any case, anti- 
q/M-globulin has access to the q/M-precursor cells either in the BE or circulation 
in amounts sufficient to inactivate them before peripheralization. On the other 
hand, in the anti-q/A-treated animals the bone marrow-derived #-chain bearing 
precursor cells are not affected and normally seed the intestinal lamina propria 
directly or perhaps via Peyer's patches as suggested by recent cell migration 
studies  (40).  We postulate  that  differences in  the concentration of the  anti- 
globulin reagent (anti-TA) in the circulation and spleen vs. the gastrointestinal 
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in the gut but not in peripheral lymphoid tissues. Important in this regard is 
the observation that antiglobulin-induced suppression is reversible and not the 
result of a  cytotoxic action (22, 24).  Alternatively, some evidence exists (41) 
that most or all of the 3,A-cells normally found in peripheral lymphoid tissues 
such as the spleen originate in the gut, and while the concentration of anti-3,A 
in  the lamina propria may be insufficient to prevent differentiation, it does 
inhibit cell migration. An additional factor could be the larger antigenic stimula- 
tion to the secretory cells in these conventionally fed animals. Effective sup- 
pression by anti-TA may also be hindered by continuous recruitment from pre- 
ceding classes  of plasma cell  precursors via  the  switch mechanism.  In fact, 
conversion from the preceding precursor may actually be enhanced by depletion 
of the class of precursor that follows in the ontogenetic sequence. 
Convincing evidence that the rather striking serum-'yA deficiency observed 
in this study is not due solely to peripheral blocking of endogenously synthe- 
sized 3'A by excess antimouse 3'A comes from the experiments showing that (a) 
anti-3,A treatment selectively suppresses splenic "yA PFC; (b) immunofluores- 
cent analysis of splenic immunoglobulin-containing plasma cells from anti-3,A- 
treated animals shows a  selective deficit of 3,A-containing cells,  and  (c)  the 
majority of animals have no demonstrable circulating anti-3,A at the time of 
testing. Also Manning (42) states that a peripheral block is unlikely as the sole 
explanation since he found no suppression of serum or fecal 3'A when anti-~,A 
treatment was begun on day 24, whereas a  transient 3'A deficiency ensued if 
treatment was initiated at birth. 
Evidence has been presented both in dogs (43) and mice (44, 45) that serum- 
3'A may be derived in large part from synthesis in cells located in the gastro- 
intestinal tract. The marked suppression of serum-'yA with essentially normal 
numbers  of 3,A-cells  in  the  gut lamina propria  observed  in  anti-3,A-treated 
animals is at first glance contrary to this hypothesis and would be analogous to 
the patients that have been reported showing a  similar dissociation between 
serum and secretory "),A (46). However, much of the ~'A normally added to the 
serum by the lamina propria cells could be prevented from reaching the circula- 
tion by the anti-~A present in the lamina propria and/or circulating anti-TA 
could remove 3'A as rapidly as it is added leaving the concentration of serum- 
3'A reduced below the level of detectability by the relatively insensitive methods 
employed in this study. This seems reasonable particularly since the concentra- 
tion of ~A in normal adult mouse serum is small, of the order of ~{0 that of the 
human. Another possibility is that the anti-~,A  present in the lamina propria 
inhibits the cellular release  of 3,A. In  the latter case the plasma cells would 
contain but not secrete 7A, a situation which has been reported in some cases 
of human myelomas (47). 
A final point that bears mentioning is that on the basis  of the model for 
sequential plasma cell  development that proceeds from 3'M to 3'G to 3'A, it 
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sion would also progress from 3"M to 3"G to ~'A. In agreement with this proposed 
sequence of events, our experiments indicate that ~,M is the first immunoglobu- 
lin to begin to recover after termination of treatment. This observation is in 
contrast to that of Manning and Jutila (22) who showed that during prolonged 
anti-3"M  treatment,  serum-'yM  remains  suppressed,  q,G  begins  to  recover 
slightly, and ~,A levels often return to normal values. The reason for this dif- 
ference in results is not apparent. 
SUMMARY 
Conventional Swiss mice were treated from birth with intraperitoneal injec- 
tions of anti-immunoglobulins in an attempt to create an experimental dysgam- 
maglobulinemia. Mice treated with anti-TM were immunologically suppressed 
in all immunoglobulin classes as determined by serum antibody titers, splenic 
plaque-forming  cells,  serum  immunoglobulin  levels,  and  immunofluorescent 
analysis of plasma cells in lymphoid tissues. Treatment immediately after birth 
with high concentrations of anti-~M  leads to a  developmental arrest charac- 
terized by severe immunosuppression,  failure to gain weight,  and premature 
death.  The pathogenesis of anti-3"M  runting syndrome is unknown.  Animals 
similarly treated with anti-3"G,  anti-3,A,  or control normal  goat or rabbit 3'- 
globulins developed normally. The frequency of occurrence and severity of anti- 
3"M-induced runting syndrome is dependent upon  the  concentration of anti- 
"yM-globulin administered. 
Administration  of anti-'yA  resulted  in  a  selective 3"A  deficiency that  was 
characterized by a marked reduction in serum-3"A and an absence of 3'A-con- 
taining cells in the spleen. However, essentially normal numbers of plasma cells 
were found in the gastrointestinal  lamina propria of anti-3,A-treated animals 
concomitantly with suppressed levels of 3'A in intestinal fluids. 
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